ONC
BeiGene, Ltd.
356.00$
-0.8%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 12.3% | 16.7% | 16.6% | 14.9% | 17.0% | 14.2% | 14.8% | 12.5% | 13.9% | 9.5% | 11.0% | 10.2% | 11.1% | |
| 87.7% | 83.3% | 83.4% | 85.1% | 83.0% | 85.8% | 85.2% | 87.5% | 86.1% | 90.5% | 89.0% | 89.8% | 88.9% | |
| 58.0% | 77.9% | 61.3% | 48.9% | 49.5% | 48.1% | 43.1% | 39.9% | 37.1% | 41.1% | 35.8% | 35.9% | 37.4% | |
| 46.8% | 65.7% | 56.9% | 47.8% | 45.4% | 44.7% | 41.1% | 40.9% | 37.5% | 37.1% | 36.7% | 34.8% | 36.4% | |
| 104.8% | 143.8% | 118.1% | 96.7% | 95.0% | 92.8% | 84.2% | 80.8% | 74.5% | 78.1% | 72.4% | 70.7% | 73.8% | |
| -17.1% | -60.5% | -34.8% | -11.5% | -12.0% | -7.0% | 1.0% | 6.7% | 11.5% | 12.4% | 16.5% | 19.1% | 15.1% | |
| – | – | – | – | – | – | 0.6% | 0.6% | – | 3.9% | 2.2% | 2.3% | – | |
| 29.4% | -55.3% | -32.4% | -11.4% | -9.8% | -7.6% | 1.9% | 7.6% | 10.4% | 10.0% | 17.1% | 18.3% | 14.2% | |
| 1.8% | 2.6% | 1.0% | 1.6% | 2.3% | 5.9% | 1.8% | 0.4% | 1.6% | 5.5% | 2.1% | 4.4% | 3.5% | |
| 27.6% | -57.9% | -33.4% | -13.0% | -12.1% | -13.5% | 0.1% | 7.2% | 8.8% | 4.4% | 15.0% | 13.9% | 10.7% | |
| 32.1% | -51.5% | -29.0% | -8.8% | -2.7% | -3.1% | 5.4% | 10.3% | 13.1% | 16.6% | 22.0% | 23.0% | 18.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.